SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India - Quaterly Results

30 Jul 2024 Evaluate
A minor change in the total revenue was seen in the June 2024 quarter. The total revenue for the quarter stood at Rs. 8519.50 millions against Rs. 8210.00 millions during year ago period.A humble growth in net profit of 17.46% reported in the quarter ended June 2024 to Rs. 937.79  millions from Rs. 798.40 millions.Operating profit surged to 1792.23 millions from the corresponding previous quarter of 1572.10 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 8519.50 8210.00 3.77 8519.50 8210.00 3.77 37550.91 39312.00 -4.48
Other Income 18.08 4.36 314.68 18.08 4.36 314.68 57.77 99.32 -41.83
PBIDT 1792.23 1572.10 14.00 1792.23 1572.10 14.00 8071.37 8481.71 -4.84
Interest 175.17 147.88 18.45 175.17 147.88 18.45 719.98 386.74 86.17
PBDT 1617.06 1424.22 13.54 1617.06 1424.22 13.54 7351.39 8094.97 -9.19
Depreciation 358.47 352.67 1.64 358.47 352.67 1.64 1438.48 1455.57 -1.17
PBT 1258.59 1071.55 17.46 1258.59 1071.55 17.46 5912.91 6639.40 -10.94
TAX 320.80 273.15 17.44 320.80 273.15 17.44 1553.73 1651.55 -5.92
Deferred Tax 10.53 17.54 -39.97 10.53 17.54 -39.97 47.68 -50.51 -194.40
PAT 937.79 798.40 17.46 937.79 798.40 17.46 4359.18 4987.85 -12.60
Equity 242.37 242.04 0.14 242.37 242.04 0.14 242.37 242.04 0.14
PBIDTM(%) 21.04 19.15 9.86 21.04 19.15 9.86 21.49 21.58 -0.37

Granules India Share Price

654.40 3.60 (0.55%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×